Literature DB >> 17165763

Cell-permeable peptide nucleic acid designed to bind to the 5'-untranslated region of E-cadherin transcript induces potent and sequence-specific antisense effects.

Anca Dragulescu-Andrasi1, Srinivas Rapireddy, Gaofei He, Birendra Bhattacharya, Jens J Hyldig-Nielsen, Gerald Zon, Danith H Ly.   

Abstract

Establishing a general and effective method for regulating gene expression in mammalian systems is important for many aspects of biological and biomedical research. Herein we report the antisense activities of a cell-permeable, guanidine-based peptide nucleic acid (PNA) called GPNA. We show that a GPNA oligomer designed to bind to the transcriptional start-site of human E-cadherin gene induces potent and sequence-specific antisense effects and is less toxic to the cells than the corresponding PNA-polyarginine conjugate. GPNA confers its silencing effect by blocking protein translation. The findings reported in this study provide a molecular framework for designing the next generation cell-permeable nucleic acid mimics for regulating gene expression in live cells and intact organisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17165763     DOI: 10.1021/ja063383v

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  23 in total

1.  Recognition of double-stranded RNA by guanidine-modified peptide nucleic acids.

Authors:  Pankaj Gupta; Oluwatoyosi Muse; Eriks Rozners
Journal:  Biochemistry       Date:  2011-12-20       Impact factor: 3.162

Review 2.  Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity.

Authors:  Maria Moccia; Mauro F A Adamo; Michele Saviano
Journal:  Artif DNA PNA XNA       Date:  2016-01-11

3.  Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5.

Authors:  Raman Bahal; Nicole Ali McNeer; Danith H Ly; W Mark Saltzman; Peter M Glazer
Journal:  Artif DNA PNA XNA       Date:  2013 Apr-Jun

4.  β-Catenin knockdown in liver tumor cells by a cell permeable gamma guanidine-based peptide nucleic acid.

Authors:  Evan Delgado; Raman Bahal; Jing Yang; Jung M Lee; Danith H Ly; Satdarshan P S Monga
Journal:  Curr Cancer Drug Targets       Date:  2013-10       Impact factor: 3.428

5.  Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.

Authors:  Shipra Malik; Jihoon Lim; Frank J Slack; Demetrios T Braddock; Raman Bahal
Journal:  J Control Release       Date:  2020-08-21       Impact factor: 9.776

Review 6.  Nanotechnology for delivery of peptide nucleic acids (PNAs).

Authors:  Anisha Gupta; Raman Bahal; Meera Gupta; Peter M Glazer; W Mark Saltzman
Journal:  J Control Release       Date:  2016-01-08       Impact factor: 9.776

7.  Antitumor effects of EGFR antisense guanidine-based peptide nucleic acids in cancer models.

Authors:  Sufi M Thomas; Bichismita Sahu; Srinivas Rapireddy; Raman Bahal; Sarah E Wheeler; Eva M Procopio; Joseph Kim; Sonali C Joyce; Sarah Contrucci; Yun Wang; Simion I Chiosea; Kira L Lathrop; Simon Watkins; Jennifer R Grandis; Bruce A Armitage; Danith H Ly
Journal:  ACS Chem Biol       Date:  2012-11-09       Impact factor: 5.100

8.  Synthesis of conformationally preorganized and cell-permeable guanidine-based gamma-peptide nucleic acids (gammaGPNAs).

Authors:  Bichismita Sahu; Venugopal Chenna; Kira L Lathrop; Sufi M Thomas; Gerald Zon; Kenneth J Livak; Danith H Ly
Journal:  J Org Chem       Date:  2009-02-20       Impact factor: 4.354

9.  Recent advances in chemical modification of Peptide nucleic acids.

Authors:  Eriks Rozners
Journal:  J Nucleic Acids       Date:  2012-09-06

10.  Cellular uptakes, biostabilities and anti-miR-210 activities of chiral arginine-PNAs in leukaemic K562 cells.

Authors:  Alex Manicardi; Enrica Fabbri; Tullia Tedeschi; Stefano Sforza; Nicoletta Bianchi; Eleonora Brognara; Roberto Gambari; Rosangela Marchelli; Roberto Corradini
Journal:  Chembiochem       Date:  2012-05-25       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.